Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive crawled date : 2021 - 05 - 20 save search
Inspire Medical Systems, Inc. Announces Positive Coverage Policy Issued by Anthem for Inspire Therapy
Published: 2021-05-20 (Crawled : 22:00) - globenewswire.com
INSP | $223.14 -3.71% 0.0% 270K
|
Health Technology
|
| O: 5.1%
H: 0.51%
C: -4.6%
positive therapy
UPDATE – Inspire Medical Systems, Inc. Announces Positive Coverage Policy Issued by Anthem for Inspire Therapy
Published: 2021-05-20 (Crawled : 22:00) - globenewswire.com
INSP | $223.14 -3.71% 0.0% 270K
|
Health Technology
|
| O: 5.1%
H: 0.51%
C: -4.6%
positive therapy
Applying Our Position As A Technology Leader To Do Good In The Community
Published: 2021-05-20 (Crawled : 13:00) - pensaregrp.com
AVCT | $0.598 -11.01% 0.33% 0
|
Finance
|
| O: 0.66%
H: 1.96%
C: -0.33%
technology positive
Genpact, EdCast, and Positive Planet US Partner to Provide Free Online Learning to Under-resourced Entrepreneurs
Published: 2021-05-20 (Crawled : 13:00) - prnewswire.com
G | $30.65 -1.79% 0.0% 960K
|
Commercial Services
|
| O: 0.41%
H: 1.35%
C: 0.98%
positive
Immunome Announces Additional $4.3 Million Award by DOD following Positive Preclinical Testing Results on COVID-19 Variants of Concern
Published: 2021-05-20 (Crawled : 12:00) - biospace.com/
IMNM | $18.84 -8.46% -9.24% 720K
|
Health Technology
|
| O: 2.21%
H: 4.86%
C: -2.7%
covid test positive results preclinical pre-clinical
Theratechnologies Announces Results From Two Posters Presented at ACTHIV 2021 Annual Meeting Highlighting Positive Patient Experience With Trogarzo®
Published: 2021-05-20 (Crawled : 12:00) - globenewswire.com
THTX | $1.33 -6.34% -6.77% 58K
|
Health Technology
|
| O: -0.27%
H: 4.66%
C: 3.01%
positive results hiv
Merck Announces Positive Topline Results from PNEU-DIRECTION (V114-027) and PNEU-PLAN (V114-024) Phase 3 Pediatric Studies for V114, Merck’s Investigational 15-valent Pneumococcal Conjugate Vaccine
Published: 2021-05-20 (Crawled : 11:00) - biospace.com/
MRK | $126.19 0.36% 0.15% 6.2M
|
Health Technology
|
| O: -4.02%
H: 1.34%
C: 0.92%
positive results topline vaccine phase 3 pneumococcal
Sorrento Reports Positive Initial Result in Dosing of First Enbrel-Non-Responding Rheumatoid Arthritis Patient With the Sofusa® Lymphatic Drug Delivery Device
Published: 2021-05-20 (Crawled : 02:00) - globenewswire.com
SRNE | $0.3073 -20.27% -8.85% 0
|
Health Technology
|
| O: 1.43%
H: 4.24%
C: 1.98%
rheumatoid arthritis positive drug device drug delivery liver
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.